zheng lei – Trademark Portfolio
Entity Type: 01
zheng lei owns a portfolio of 13 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), including well-known marks such as JAROMO, LIFEVV, JONAPAR, MAFILOP, and MIORICK. Of these, 8 are registered and 1 is pending. The portfolio spans 9 Nice Classification classes, led by Class 25 (Clothing) and Class 30 (Staple Foods). Headquartered in Shanghai.
Pudong district shangcheng road No.1225
Shanghai 200120 , CN
Showing of trademarks Trademarks
Trademark Classifications
zheng lei's trademark portfolio spans 9 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Coffee, tea, cocoa and artificial coffee; rice; tapioca and sago; flour and preparations
Building materials (non-metallic); non-metallic rigid pipes for building
Precious metals and their alloys; jewellery, precious stones; horological instruments
Paper and cardboard; printed matter; bookbinding material; photographs; stationery
Apparatus for lighting, heating, steam generating, cooking, refrigerating, drying
Frequently Asked Questions
How many trademarks does zheng lei have?
zheng lei has 13 U.S. trademarks filed with the USPTO. Of these, 8 registered, 1 pending, 3 abandoned, 1 cancelled.
What trademark classes does zheng lei file in?
zheng lei files trademarks across 9 Nice Classification classes. The most active classes are Class 25 (Clothing), Class 30 (Staple Foods), Class 20 (Furniture), Class 19 (Building Materials), Class 14 (Jewelry). Class 25 covers clothing, footwear, headgear.
What are zheng lei's most well-known trademarks?
zheng lei's registered trademark portfolio includes well-known marks such as JAROMO, LIFEVV, JONAPAR, MAFILOP, and MIORICK. These are among 8 currently registered trademarks in the portfolio.
What is zheng lei's trademark registration success rate?
zheng lei has a 67% trademark registration rate, with 8 out of 12 resolved applications resulting in successful registration. Currently, 1 application is pending review.